The management of neoplastic disorders of haematopoiesis in children with Down's syndrome

British Journal of Haematology

Volumn 110, Issue 3, 2000, Pages 512-524

  Lange, Beverly ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Acute leukaemia; Down's syndrome; Myelodysplastic syndrome; Transient myeloproliferative disorder

Indexed keywords

CYTARABINE; CYTOTOXIC AGENT; GAMMA INTERFERON; METHOTREXATE; RETINOL PALMITATE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER THERAPY; CHILDHOOD LEUKEMIA; CHROMOSOME 21; CLINICAL FEATURE; DISEASE COURSE; DOWN SYNDROME; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; INCIDENCE; MYELOPROLIFERATIVE DISORDER; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; DOWN SYNDROME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, MYELOID; MALE; MATERNAL AGE; MYELOPROLIFERATIVE DISORDERS; PREDNISONE; REMISSION INDUCTION; VINCRISTINE;

EID: 0033780541     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02027.x     Document Type: Review

References (131)

1. Disomic homozygosity in 21 trisomic cells: A mechansm responsible for transient myeloproliferative syndrome
2. Cytogenetic pattern in leukemic cells of patients with constitutional chromosome anomalies
3. Bone marrow transplantation for acute leukemia and Down syndrome: Report of a successful case and results of a national survey
4. Clonal hematologic disorders in Down syndrome
5. Megakaryoblastic leukemia presenting as acute myelofibrosis - A study of four cases with platelet peroxidase reaction
6. Life expectancy in Down Syndrome
7. Acute megakaryocytic leukemia (AMKL, FAB M7) in children with and without Down syndrome (DS) treated on Children's Cancer Group protocol CCG-2891
8. Acute nonlymphocytic leukemia after transient myeloproliferative disorder in a patient with down syndrome
9. Perinatal visceral fibrosis accompanying the megakaryoblastic leukemoid reaction of Down syndrome
10. Reduced folate carrier expression in acute lymphoblastic leukemia: A mechanism for ploidy but not lineage differences in methotrexate accumulation
11. Criteria for the diagnosis of acute leukemia M7 of megakaryocetic lineage: A report from the French-American-British Cooperative Group
12. Acute lymphoblastic leukemia and chromosome 21
13. Congenital leukemia
14. Leukemia of platelet precursors: Diverse features in four cases
15. Transient leukemia with trisomy 21: Description of a case and review of the literature
16. Excessive chemotherapy-related myelotoxicity in children with Down syndrome and acute lymphoblastic leukaemia
17. Thrombopoietin level is inversely related to blast count, not platelets number, in Down syndrome neonates with transient myeloproliferative disorder
18. Acute lymphatic leukemia: Report of case in eleventh month mongolian idiot
19. Chromosome 7 abnormalities in children with down syndrome and preleukemia
20. Acute megakaryoblastic leukaemia in children
21. Cytogenetic and molecular study of 32 Down syndrome families: Potential leukaemia predisposing role of the most proximal segment of chromosome 21q
22. Acute megakaryoblastic leukemia in early childhood
23. Bone marrow transplantation, physician bias, and Down syndrome: Ethical reflections
24. Clinical significance of surface antigen expression in children with acute myeloid leukemia. Results of Study AML-BFM-87
25. Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A Report of 40 Children of the AML-BFM Study Group
26. Molecular mapping of 24 features of Down syndrome of chromosome 21
27. Megakaryoblastic leukaemia (acute myelofibrosis): A report of three cases
28. Down's syndrome in childhood acute lymphoblastic leukemia: Clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Munster Group
29. Observations on an ethnic classification of idiots
30. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: Biology and clinical significance
31. Defective repair of oxidative damage in mitochondrial DNA in Down's syndrome
32. Transient congenital leukemia in seven infants with mongolism
33. Acute myelofibrosis in children with Down's syndrome
34. Leukemia in a trisomy 21 mosaic: Specific involvement of the trisomic cells
35. Incidence of circulating cells positive for GpIb and GpIIIa in infants with Down's syndrome
36. Down's syndrome and leukemia: Epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis
37. Kalmuc idiocy
38. Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia
39. Cytogenetic findings in leukemic cells of 56 patients with constitutional chromosome abnormalities. A cooperative study
40. The origin of trisomy in humans. Etiology and pathogenesis of Down syndrome
41. Transient leukemoid proliferation of the cytogenetically unbalanced +21 cell line of a constitutional mosaic boy
42. Chromosome clues to acute leukemia in Down's syndrome
43. Acute lymphoblastic leukemia (ALL) in children with Down syndrome (DS): A report from the Children's Cancer Group (CCG)
44. Dinucleotide deletions in neuronal transcripts: A novel type of mutation in non-familial Alzheimer's disease and Down syndrome patients
45. Acute leukemia with megakaryocytic differentiation: A study of 12 cases identified immunocytochemically
46. Chromosome 21 and platelets: A gene dosage effect
47. Leukaemia and transient leukaemia in Down syndrome
48. Expression of erythroid-specific genes in megakaryoblastic disorders
49. Increased levels of a chromosome 21-encoded tumour invasion of metastasis factor (TIAMI) mRNA in bone marrow of Down syndrome children during the acute phase of AML (M7)
50. Clinical and biological characteristics of acute lymphocytic leukemia in children with Down syndrome
51. Chromosome abnormalities in Down Syndrome patients with acute leukemia
52. Deletions of chromosome 21 restricted to the leukemic cells of children with Down syndrome and leukemia
53. Down syndrome and acute leukemia in children: An analysis of phenotype by use of monoclonal antibodies and electron miroscopic platelet peroxidase
54. Favourable treatment outcome in children with acute myeloid leukemia and Down syndrome
55. Advances in the understanding of chromosome 21 and Down syndrome
56. A high-fidelity physical map of human chromosome 21q in yeast artificial chromosomes
57. Myelodysplastic syndrome after regression of transient abnormal myelopoiesis in a Down syndrome infant: Different clonal origin?
58. Simultaneous occurrence of mongolism and leukemia
59. Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia in childhood: A Pediatric Oncology Group Study
60. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome
61. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome. Children's Cancer Group Studies 2861 and 2891
62. The common TEL/AML 1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occuring in children with Down syndrome
63. The myeloproliferative reaction in a child with down syndrome: Cytological and chromosomal evidence for a transient leukemia
64. CBFA21, frequently rearranged in leukemia is not responsible for a familial leukemia syndrome
65. Etude des chromosomes somatiques de neuf enfants mongoliens
66. Metabolism of monocarbons and trisomy 21: Sensitivity to methotrexate
67. The immune system and susceptibility to infections in Down's Syndrome
68. Prognosis of Down's syndrome with acute leukaemia
69. Association between megakaryoblastic leukemia and Down syndrome
70. Acute megakaryoblastic leukemia in childhood
71. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: Best outcome in girls, infants, and children with Down's syndrome
72. Congenital leukemoid reaction followed by fatal leukemia: A case with Down's syndrome
73. Trisomy 21 is a recurrent secondary aberration in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion
74. Characterization and molecular analysis of nondisjunction in 18 cases of trisomy 21 and leukemia
75. t(5;7) (q34;q21) in acute megakaryoblastic leukemia associated with Down syndrome
76. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia
77. Acute megakaryoblastic leukemia
78. Trisomy 21 in neoplastic cells
79. Clonal analysis of transient myeloproliferative disorder in Down's syndrome
80. Usual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's Syndrome: A report of four autopsy cases and proposal of a hypothesis
81. Leukemia with Down's Syndrome. Translocation between chromosomes 1 and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome
82. A neonate with Down's syndrome and transient abnormal myelopoiesis: Serial blood and bone marrow studies
83. Hyperviscosity syndrome with transient abnormal myelopoiesis in Down syndrome
84. Down's Syndrome: The possibility of a pathogenetic segment of chromosome 21
85. Transient abnormal myelopoiesis followed by extramedullary tumors
86. AML1 and the 8;21 and 3;21 translocations in acute and chronic meyloid leukemia
87. The story of Baby Doe
88. Immunophenotypes and karyotypes of leukemic cells in children with Down Syndrome and acute lymphoblastic leukemia
89. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone
90. Clinical characteristics and treatment outcome in children with acute lymphocytic leukemia in Down's syndrome
91. Acute myeloid leukemia (AML) in Down's syndrome in highly responsive to chemotherapy: Experience on Pediatric Oncology Group AML Study 8498
92. Down syndrome and leukemia
93. Down syndrome and acute leukemia in children: A 10-year retrospective survey from Children's Cancer Study Group
94. Duplication and loss of chromosome 21 in two children with Down syndrome and acute leukemia
95. The myeloproliferative syndrome in children
96. Down's syndrome and acute leukemia: Myeloblastic or lymphoblastic?
97. Therapy-related myelodysplastic syndromes and acute myeloid leukemia in children in correlation between chromosomal abnormalities and prior therapy
98. Severe perinatal liver disease and Down syndrome: An apparent relationship
99. Acute megakaryoblatic leukaemia: A prospective study of its identification and treatment
100. Acute myelogenous leukaemia with t (8;21) translocation of normal cell origin in mosaic Down's syndrome with isochromosome 21q
101. De novo acute megakaryoblastic leukemia (AMKL) in children. A study of 22 cases
102. Down syndrome, transient meyloproliferative disorder, and infantile liver fibrosis
103. Ph-positive CML in blastic phase with monosomy 7 in a Down syndrome patient. Monitoring by interphase cytogenetics and demonstration of maternal allelic loss
104. Six cases of Down's syndrome with leukemia-like blood picutre: Leukemia and transient abnormal myelopoiesis (TAM)
105. Leukemic blasts with markers of four cell lineages in Down's syndrome ('megakaryoblastic leukemia')
106. Expression of lymphoid associated antigens by childhood acute myeloid leukemia cells loads prognostic significance
107. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukemia
108. A survey of childhood malignancies
109. Clonal analysis of basophil differentiation in bone marrow cultures from a Down's syndrome patient with megakaryoblastic leukemia
110. Acute myelodysplasia with myelofibrosis: A report of eight cases
111. Enhanced metabolism of 1-B-D-Arabinofuranosylcytosine in Down syndrome cells: A contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia
112. Expression of chromosome 21-localized genes in acute myeloid leukemia: Differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin
113. Erythroblastic and/or megakaryoblastic leukemia in Down syndrome: Treatment with low-dose arabinosyl cytosine
114. Methotrexate sensitivity in DS: A hypothesis
115. Leukemia associated with mongolism
116. Nonrandom chromosomal aberrations and clonal chromosomal evolution in acute leukemia associated with Down's syndrome
117. Evidence for reduced recombination on the nondisjoined chromsomes 21 in Down syndrome
118. Trisomy 21 in children with acute lymphoblastic leukemia: A Pediatric Oncology Group Study (8602)
119. Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: A Children's Cancer Group Study
120. Transient myeloproliferative disorder and acute nonlymphoblastic leukemia in Down syndrome
121. Timed-sequential induction therapy improves post-remission outcome in acute myeloid leukemia (AML): A report from the Children's Cancer Group
122. Acute meyloblastic leukemia associated with trisomy 8 and translocation 8;21 in a child with Down syndrome
123. DSCAM: A novel member of the immunoglobulin superfamily maps in a Down syndrome region and is involved in the development of the nervous system
124. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis
125. The treatment of children with acute megakaryoblastic leukemia who have Down syndrome
126. Megakaryoblastic leukemia and Down's syndrome: A review
127. Hematologic and oncologic disorders in Down syndrome
128. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome
129. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome
130. Acute myelogenous leukemia in Down's syndrome: Report of a single pediatric institution using a BFM treatment strategy